| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
57,816 |
53,411 |
$2.15M |
| 0270 |
|
20,537 |
11,528 |
$672K |
| 0250 |
|
6,332 |
4,177 |
$336K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
1,873 |
1,573 |
$290K |
| J3490 |
Unclassified drugs |
2,507 |
2,133 |
$273K |
| 80053 |
Comprehensive metabolic panel |
8,392 |
7,868 |
$237K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,351 |
6,611 |
$204K |
| 99199 |
Unlisted special service, procedure or report |
1,490 |
1,440 |
$176K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,853 |
3,409 |
$124K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
673 |
271 |
$54K |
| 71046 |
Radiologic examination, chest; 2 views |
1,722 |
1,658 |
$54K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,472 |
1,429 |
$51K |
| 71045 |
Radiologic examination, chest; single view |
5,492 |
5,266 |
$50K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,345 |
2,283 |
$39K |
| 85027 |
|
19,890 |
17,877 |
$37K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,570 |
1,526 |
$35K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,564 |
8,861 |
$31K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,682 |
6,170 |
$31K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,101 |
2,007 |
$29K |
| 81003 |
|
3,983 |
3,703 |
$29K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,498 |
2,132 |
$26K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
823 |
815 |
$26K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
374 |
374 |
$19K |
| 84484 |
|
4,627 |
4,068 |
$17K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
450 |
427 |
$16K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,447 |
2,077 |
$16K |
| 87081 |
|
319 |
314 |
$15K |
| 87632 |
|
176 |
168 |
$14K |
| 87430 |
|
322 |
317 |
$12K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
207 |
185 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
686 |
640 |
$10K |
| 73562 |
|
84 |
83 |
$8K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
421 |
396 |
$8K |
| 73610 |
|
125 |
125 |
$8K |
| 0272 |
|
1,526 |
1,434 |
$8K |
| 87077 |
|
314 |
304 |
$7K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
104 |
50 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,164 |
2,732 |
$7K |
| 83690 |
|
5,641 |
5,306 |
$7K |
| 73630 |
|
124 |
123 |
$7K |
| 81001 |
|
2,562 |
2,471 |
$6K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
377 |
371 |
$6K |
| 84702 |
|
239 |
214 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
322 |
321 |
$6K |
| 87400 |
|
84 |
82 |
$5K |
| 80305 |
|
193 |
174 |
$5K |
| 36416 |
|
181 |
171 |
$5K |
| 81025 |
|
791 |
768 |
$4K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
215 |
190 |
$4K |
| 82553 |
|
1,464 |
1,275 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
572 |
535 |
$4K |
| 84703 |
|
2,289 |
2,148 |
$3K |
| 87486 |
|
403 |
378 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
212 |
199 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
268 |
262 |
$3K |
| 82550 |
|
1,866 |
1,622 |
$3K |
| 80076 |
|
2,443 |
2,255 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
777 |
759 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
437 |
409 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
202 |
192 |
$3K |
| 85610 |
|
786 |
728 |
$3K |
| 83735 |
|
927 |
826 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,423 |
4,833 |
$2K |
| 87040 |
|
1,134 |
912 |
$2K |
| 82248 |
|
3,739 |
3,644 |
$2K |
| 85730 |
|
432 |
410 |
$2K |
| 86901 |
|
320 |
309 |
$2K |
| 85007 |
|
1,635 |
1,480 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
105 |
105 |
$1K |
| 73140 |
|
12 |
12 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,880 |
2,545 |
$1K |
| 83880 |
|
966 |
922 |
$932.98 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$925.92 |
| 72100 |
|
27 |
27 |
$907.82 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
54 |
54 |
$848.00 |
| 73130 |
|
14 |
13 |
$632.82 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,815 |
2,276 |
$527.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
724 |
673 |
$518.35 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
29 |
29 |
$511.87 |
| 86900 |
|
320 |
309 |
$502.39 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
967 |
941 |
$462.78 |
| 83605 |
|
1,068 |
955 |
$449.56 |
| 87186 |
|
365 |
353 |
$441.54 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
424 |
354 |
$389.05 |
| 87581 |
|
403 |
378 |
$361.01 |
| 73030 |
|
12 |
12 |
$327.27 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
403 |
378 |
$320.72 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
343 |
295 |
$317.75 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
37 |
37 |
$313.33 |
| 96376 |
|
634 |
479 |
$301.67 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
468 |
423 |
$277.19 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15 |
12 |
$237.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
275 |
269 |
$230.30 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
115 |
114 |
$213.48 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$166.51 |
| 76830 |
Ultrasound, transvaginal |
103 |
100 |
$155.26 |
| 85379 |
|
94 |
93 |
$146.71 |
| 86850 |
|
30 |
29 |
$120.51 |
| A9270 |
Non-covered item or service |
763 |
335 |
$73.09 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
35 |
33 |
$57.09 |
| 87420 |
|
72 |
71 |
$54.94 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
213 |
200 |
$50.29 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
17 |
13 |
$40.46 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
72 |
70 |
$31.80 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
73 |
71 |
$31.80 |
| J7050 |
Infusion, normal saline solution, 250 cc |
74 |
61 |
$19.61 |
| J2060 |
Injection, lorazepam, 2 mg |
134 |
120 |
$19.28 |
| 80306 |
|
39 |
36 |
$15.96 |
| 87147 |
|
13 |
13 |
$5.11 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
24 |
24 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
27 |
27 |
$0.00 |
| 90715 |
|
14 |
14 |
$0.00 |